Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This technical breakout will receive added boost. Let's not forget the Short Interest of Float is:
17.37% of 96.4 M = 16.7M shares.
RA Capital accumulated a huge position since the decline, and the company has a humongous cash pile with a decent pipeline. The clinical hold on sovapravir will be released once it is clear that the elevated LFTs were due to drug-drug interaction (from HIV co-drug in that trial).
Expect nice short-term pop, and LT trend much higher!
GO ACHN!!
Ditto, sps, you seem to be a good man --please stay on board! Our time is very near IMO.
GO SUPER LBSR!!
Thank you, Leif!
GO SUPER LBSR!!
Thank you, mucho $!
Any guess on time frame?
GO SUPER LBSR!!
Leif,
Any guess on time-frame to expect drilling news/JV?? We need to await the SRK update, but beyond that?
GO SUPER LBSR!!
Are you sincerely convinced that we will not see a major JV within the next 3-6 mos?
GO SUPER LBSR!!
Actually it would hurt LBSR if large quantities of REE's are found amongst the dregs...
Nevertheless,
GO SUPER LBSR!!
The highlight:
http://online.wsj.com/news/articles/SB10001424052702303870704579298810741503846
REE's may catch a bid with this news...
GO SUPER LBSR!!
Dude, where is sub-2-penny, I ask repeatedly, and receive no answer, and you are a moderator no less!? We are up > 100% from this year's lows --prepare the rocketship for more!
GO SUPER LBSR!!
Didn't make it to FS this time, but rather stayed in Kingman...nice folks, and a great restaurant (Calicos)...I forget how barren dessert really is, living in the Appalachia. Mining lore was palpable in many parts!
GO SUPER LBSR!!
I'm actually on vacation right now in Vegas --took a trip to Arizona though, but only the northern part. Had never seen the Grand Canyon, believe it or not. Drove close to our uranium claims --but saw no drills...should see drills in HM much sooner, no doubt!
GO SUPER LBSR!!
Good idea, as well as including Cu price graph and updating the maps...
Happy New Year everyone!
GO SUPER LBSR!!
Same to you MAM and Happy Holidays to all LBSR'ers!
And GLTU all!!
GO SUPER LBSR!!
...and we hardly budged! I think we have a valuable option in BCSP, but the real money to be made in the near term will come from HM/TS. Should Pebble be permitted, then I stand sternly (and happily) corrected.
Do folks think we'll go it alone on the drilling, or wait for a JV?
GO SUPER LBSR!!
Condolences to you and your family...
...LBSR on a steady climb with consolidation at higher levels last few days.
GO SUPER LBSR!!
We hit it a few times in last week, but sustainably probably not before the new year...what are you thoughts?
GO SUPER LBSR!!
Dude, where is sub-2-penny??
GO SUPER LBSR!!
... scents of ripening fruit.
Harvest time!
GO SUPER LBSR!!
Yes, we all are hopefully more sophisticated than that!
GO SUPER LBSR!!
Excellent point/observation, Yang!
I love our chances...
GO SUPER LBSR!!
For chartists, we clearly have a cup & handle with volume breakout --I would be starting a position if I were on the side-lines here...
GO SUPER LBSR!!
JB reminded us of the extremely competitive nature of the area, so I expect we could see additional staking (likely to the "south") at any moment...
BTW, great day for LBSR pps --chart looking juicy and will pick up some traders no doubt. Maybe we can convert them to investors!? <smile>
GO SUPER LBSR!!
I like it!
Should put some room between us and the competition!
Any idea when we will get clarification on CMS reimbursement on our testing?
GO MYGN!!
A doubling of intriguing targets @ HM should raise many eyebrows amongst the mega-miners!
GO SUPER LBSR!!
Thanks koa!
Here's a couple of links if others are interested:
http://www.tombstonemining.com/index.php?option=com_content&view=article&id=89:tombstone-exploration-corporation-receives-confirmation-of-high-silver-gold-and-lead-assay-values-releases-property-mineralization-report-to-shareholders&catid=53:2008-news-releases&Itemid=62
http://www.ibtimes.com/tombstone-exploration-corp-tmbxfob-adds-important-nevada-holding-its-portfolio-425589
http://baroyeca.com/portfolio/tombstone/
GO SUPER LBSR!!
Even if the grade were modest, with that much volume (i.e. "humongous") --we're still golden (leaden, silvered, moly'd, and REE'd too)...
I say folks who aren't in LBSR at this point, are going to missing a MAJOR move soon.
GO SUPER LBSR!!
Can any one find a summary of ore grades of prior Tombstone mining projects?
Of course, let's not forget that Bisbee is only 25 miles away, and that ZTEM may help us lock in the best targets.
GO SUPER LBSR!!
Thank you Gem!
Always keeping us based in reality and with very reasonable optimism.
I am ready to sink a pile more $ into LBSR with the right NR...
GO SUPER LBSR!!
Let's not forget, he/we also jettisoned Bonanza Hills --so JB has shown some financial judiciousness for a while.
GO SUPER LBSR!!
Yes, agree FCX would be very logical. I too would add substantially --perhaps double my stake.
GO SUPER LBSR!!
I think that the stock is finally reacting to the excellent news regarding Chinese acceptance of our cerebral oximeter. Perhaps the news was camoflaged by Thanksgiving holidays!?
We have here a well-capitalized, very reasonably priced company with great growth prospects. The volume today will finally attract some well deserved attention!
The only other wish-list item would be some substantial insider-buys...
GO CASM!!
The best post in some time --thanks for encapsulating the bull case so well, Mr. Kipp!
GO SUPER LBSR!!
...the waiting part is probably why we're down. Fine w/ me...we are extremely close to a major pay day folks. This is a wonderful update!
GO SUPER LBSR!!
These were the data that initially didn't impress:
Obes Surg. 2012 Nov;22(11):1771-82. doi: 10.1007/s11695-012-0751-8.
The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity.
Sarr MG, Billington CJ, Brancatisano R, Brancatisano A, Toouli J, Kow L, Nguyen NT, Blackstone R, Maher JW, Shikora S, Reeds DN, Eagon JC, Wolfe BM, O'Rourke RW, Fujioka K, Takata M, Swain JM, Morton JM, Ikramuddin S, Schweitzer M, Chand B, Rosenthal R; EMPOWER Study Group.
Source
Mayo Clinic, Rochester, MN, USA. sarr.michael@mayo.edu
Abstract
BACKGROUND:
Intermittent, reversible intraabdominal vagal blockade (VBLOC® Therapy) demonstrated clinically important weight loss in feasibility trials. EMPOWER, a randomized, double-blind, prospective, controlled trial was conducted in USA and Australia.
METHODS:
Five hundred three subjects were enrolled at 15 centers. After informed consent, 294 subjects were implanted with the vagal blocking system and randomized to the treated (n = 192) or control (n = 102) group. Main outcome measures were percent excess weight loss (percent EWL) at 12 months and serious adverse events. Subjects controlled duration of therapy using an external power source; therapy involved a programmed algorithm of electrical energy delivered to the subdiaphragmatic vagal nerves to inhibit afferent/efferent vagal transmission. Devices in both groups performed regular, low-energy safety checks. Data are mean ± SEM.
RESULTS:
Study subjects consisted of 90 % females, body mass index of 41 ± 1 kg/m(2), and age of 46 ± 1 years. Device-related complications occurred in 3 % of subjects. There was no mortality. 12-month percent EWL was 17 ± 2 % for the treated and 16 ± 2 % for the control group. Weight loss was related linearly to hours of device use; treated and controls with = 12 h/day use achieved 30 ± 4 and 22 ± 8 % EWL, respectively.
CONCLUSIONS:
VBLOC® therapy to treat morbid obesity was safe, but weight loss was not greater in treated compared to controls; clinically important weight loss, however, was related to hours of device use. Post-study analysis suggested that the system electrical safety checks (low charge delivered via the system for electrical impedance, safety, and diagnostic checks) may have contributed to weight loss in the control group.
The key here is statistical significance --as I recall that was the big bugaboo with the last published data, i.e. safe but not better than sham.
This study should have some pull!
Patients need this option --many who have banding or bypass really hate the dietary restrictions, and many have tried and failed diet pills.
GO ETRM!!
EnteroMedics announces 18 month ReCharge study results; VBLOC therapy continues to demonstrate durable and safe weight loss
7:01 AM ET 12/3/13 | Briefing.com
Co announced 18 month efficacy and safety results from its 5 year ReCharge Pivotal Trial of VBLOC vagal blocking therapy for the treatment of obesity. Patients in the VBLOC group (n=117), achieved excess weight loss (EWL) of 25%, or 10% total body weight loss (TBL), compared to 12% EWL, or 4% TBL for sham control group patients (n=42). The 13% difference in EWL demonstrated statistical superiority over sham control (p < 0.001).
In total, 54% of patients in the VBLOC group achieved at least 20% EWL and 41% achieved at least 25% EWL, compared to 26% and 17%, respectively, for the sham control group at the 18-month interval. Significantly, approximately 78% of the patients who reported for their 18-month visit remained under the clinical trial's randomized blind. The rate of device-related serious adverse events at 18 months was 4.3% for the VBLOC group, meaningfully lower than the 12 month threshold of 15% (p < 0.0001).
The safety results continued to confirm VBLOC Therapy had no adverse cardiovascular effects. Overall, a reduction in blood pressure and heart rate was observed.
Ariad's AP26113 had robust antitumor activity in crizotinib-resistant and crizotinib-naive NSCLC patients,
including those with brain metastasis after crizotinib treatment.
Most if not all patients with NSCLC will become resistant to crizotinib, and half of those who are resistant have brain metastasis,” explained lead author D. Ross Camidge, MD, PhD, Associate Professor and Director of the Thoracic Oncology Clinical Program at University of Colorado, Denver.
AP26113 was generally well tolerated. Common adverse events of all grades were nausea (38%), fatigue (34%), and diarrhea (32%); 12% had elevated liver enzymes. Treatment-emergent grade 3 or higher adverse events were reported in 2% to 4% across all dose levels, and included dyspnea, fatigue, diarrhea, hypoxia, and pneumonitis. Pulmonary events, which occurred early in 3/25 patients at the 180-mg/d level and seemed to be rarer at lower doses, were responsive to drug interruption, although resolution, despite continued dosing, was also reported. Future studies will employ a step-up approach, initiating the drug at 90 mg/d for 7 days before moving up to 180 mg/d.
Tapered dose steroids were used to resolve symptoms over 1 week, and patients restarted the drug at 90 mg/d without further pulmonary symptoms, he said. Future studies will employ a step-up approach, initiating the drug at 90 mg/d for 7 days before moving up to 180 mg/d.
Eight of 10 patients (80%) with preexisting CNS metastasis had radiographic evidence of regression, and ongoing improvements lasting more than 40 weeks were reported.
------
"Early Evidence Supports Novel ALK Inhibitor in Patients with Non–Small Cell Lung Cancer With Brain Metastases", by Alice Goodman, The ASCO Post, December 1, 2013, Volume 4, Issue 19
And just a bit of background:
"Non-small cell lung cancer (NSCLC) is the leading cause of mortality from cancer and the most common source of brain metastases. It is estimated that between 30 and 50% of lung cancer patients develop metastatic cancer to the brain during the course of their illness (1). Patients with untreated brain metastases have a median survival time of ~4 weeks and almost all succumb to neurological rather than systemic causes." [Oncology Letters. 2013 October; 6(4): 897–900.]
This is terrific news on initial data for AP26113!
Good news for AZC. Hopefully rubs off on us. Should clear up any environmental and/or ethnic impact concerns, which were minor for AZ to begin with...
GO SUPER LBSR!!